In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $7.46 in the prior trading day, Cogent Biosciences Inc (NASDAQ: COGT) closed at $6.99, down -6.30%. In other words, the price has decreased by -$6.30 from its previous closing price. On the day, 2.51 million shares were traded.
Ratios:
Our goal is to gain a better understanding of COGT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On February 26, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $14 to $8.
On February 08, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $11.Citigroup initiated its Buy rating on February 08, 2024, with a $11 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 14 ’25 when Pinnow Cole bought 43,750 shares for $7.60 per share. The transaction valued at 332,412 led to the insider holds 45,848 shares of the business.
Stock Price History:
Over the past 52 weeks, COGT has reached a high of $12.61, while it has fallen to a 52-week low of $5.73. The 50-Day Moving Average of the stock is -15.32%, while the 200-Day Moving Average is calculated to be -24.68%.
Shares Statistics:
A total of 110.46M shares are outstanding, with a floating share count of 92.00M. Insiders hold about 16.72% of the company’s shares, while institutions hold 94.61% stake in the company.
